Neurocrine Biosciences Inc Q1 Profit Decreases, Misses Estimates

Neurocrine Biosciences Inc (NBIX) announced earnings for first quarter that decreased from the same period last year and missed the Street estimates.

The company's earnings came in at $7.9 million, or $0.08 per share. This compares with $43.4 million, or $0.42 per share, last year.

Excluding items, Neurocrine Biosciences Inc reported adjusted earnings of $71.5 million or $0.70 per share for the period.

Analysts on average had expected the company to earn $1.09 per share. Analysts' estimates typically exclude special items.

The company's revenue for the period rose 11.1% to $572.6 million from $515.3 million last year.

Neurocrine Biosciences Inc earnings at a glance (GAAP) :

-Earnings: $7.9 Mln. vs. $43.4 Mln. last year.
-EPS: $0.08 vs. $0.42 last year.
-Revenue: $572.6 Mln vs. $515.3 Mln last year.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com